Salta al contenuto principale
Ricerc@Sapienza
Toggle navigation
Home
Login
Home
Persone
fabio.didomenico@uniroma1.it
Fabio Di Domenico
Professore Ordinario
Struttura:
DIPARTIMENTO DI SCIENZE BIOCHIMICHE "ALESSANDRO ROSSI FANELLI"
E-mail:
fabio.didomenico@uniroma1.it
Pagina istituzionale corsi di laurea
Curriculum Sapienza
Pubblicazioni
Titolo
Pubblicato in
Anno
Intranasal rapamycin ameliorates Alzheimer-like cognitive decline in a mouse model of Down syndrome
TRANSLATIONAL NEURODEGENERATION
2018
mTOR in Down syndrome: Role in Aß and tau neuropathology and transition to Alzheimer disease-like dementia
FREE RADICAL BIOLOGY & MEDICINE
2018
Targeting mTOR to reduce Alzheimer-related cognitive decline: from current hits to future therapies
EXPERT REVIEW OF NEUROTHERAPEUTICS
2017
Introductory editorial: drug-eluting stents or drug-eluting grafts? insights from proteomic analysis
DRUG TARGET INSIGHTS
2017
Role of 4-hydroxy-2-nonenal (HNE) in the pathogenesis of Alzheimer disease and other selected age-related neurodegenerative disorders
FREE RADICAL BIOLOGY & MEDICINE
2017
The triangle of death in Alzheimer's disease brain: the aberrant cross-talk among energy metabolism, mammalian target of rapamycin signaling, and protein homeostasis revealed by redox proteomics
ANTIOXIDANTS & REDOX SIGNALING
2017
Polyubiquitinylation profile in down syndrome brain before and after the development of Alzheimer neuropathology
ANTIOXIDANTS & REDOX SIGNALING
2017
Identification of changes in neuronal function as a consequence of aging and tauopathic neurodegeneration using a novel and sensitive magnetic resonance imaging approach
NEUROBIOLOGY OF AGING
2017
I principi europei sui metodi alternativi alla sperimentazione animale
Metodi alternativi alla sperimentazione animale
2017
Metodi alternativi alla sperimentazione animale
2017
From redox proteomics to clinical practice: Search for therapeutic targets
JOURNAL OF GERONTOLOGY AND GERIATRICS
2017
Increased mammalian target of rapamycin signaling contributes to the accumulation of protein oxidative damage in a mouse model of down's syndrome
NEURODEGENERATIVE DISEASES
2016
Impairment of biliverdin reductase-a promotes brain insulin resistance in Alzheimer disease: a new paradigm
FREE RADICAL BIOLOGY & MEDICINE
2016
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
AUTOPHAGY
2016
Activation of p53 in down syndrome and in the ts65dn mouse brain is associated with a pro-apoptotic phenotype
JOURNAL OF ALZHEIMER'S DISEASE
2016
Redox proteomic analysis of serum from aortic anerurysm patients: insights on oxidation of specific protein target
MOLECULAR BIOSYSTEMS
2016
It is all about (U)biquitin: role of altered ubiquitin-proteasome system and UCHL1 in Alzheimer disease
OXIDATIVE MEDICINE AND CELLULAR LONGEVITY
2016
Cathepsin D as a therapeutic target in Alzheimer’s disease
EXPERT OPINION ON THERAPEUTIC TARGETS
2016
Aberrant protein phosphorylation in Alzheimer disease brain disturbs pro-survival and cell death pathways
BIOCHIMICA ET BIOPHYSICA ACTA. MOLECULAR BASIS OF DISEASE
2016
Autoantibodies profile in matching CSF and serum from AD and aMCI patients: potential pathogenic role and link to oxidative damage
CURRENT ALZHEIMER RESEARCH
2016
« prima
< precedente
1
2
3
4
seguente ›
ultima »
Progetti di Ricerca
Deciphering the the interplay between the unfolded protein response and insulin resistance in Down syndrome brain
Inhibition of PERK pathway for the early treatment of Alzheimer Disease-like cognitive decline in Down Syndrome
The sweet link between aberrant brain metabolism and cognitive decline: A novel role for altered protein O-GlcNAcylation.
Deciphering the role of aberrant PERK/NRF2 axis in Down Syndrome
© Università degli Studi di Roma "La Sapienza" - Piazzale Aldo Moro 5, 00185 Roma